you are here: Home News Active Pharmaceutical Ingredients

Active Pharmaceutical Ingredients

Rakesh Jhunjhunwala-backed Concord Biotech files draft papers to float IPO
Local manufacturing of 35 APIs started after PLI scheme: Mansukh Mandaviya
USFDA pulls up Aurobindo Pharma for manufacturing lapses at API plant
PE major CVC Capital Partners in talks to pick up minority stake in Shilpa Medicare’s API business
API imports stood at Rs 28,529 crore, exports at Rs 32,856 crore in FY21: Mansukh Mandaviya
Indian pharma firms go local seeking to end reliance on China
Need to boost local API production for India to become self-reliant in coming years: Unichem Laboratories
Budget 2017: Weighted deductions for incurring pharma R&D should continue
Hikal's Bengaluru unit undergoes 'successful' USFDA inspection
Continue to be positive on housing finance companies: SP Tulsian
Laurus Labs IPO opens: Analysts bullish but say valuations high
API imports from China move up to 65% in 2015-16
Sharon Bio up 20% on USFDA approval for API plant in Maharashtra
Expect growth to continue going forward: Lincoln Pharma
Cipla in pact with Russian firm for HIV, Hepatitis C drugs
USFDA observations on 2 units not to impact products: Natco
Alkem's Mandva plant gets establishment nod from USFDA
US API import ban applies only to one drug: Biocon CMD
Mankind Pharma to invest Rs 200 cr by mid-2016
Strides Shasun suspends production at Cuddalore unit block
Granules India gets USFDA nod for generic Ibuprofen tablets
Cadila to delist from Ahmedabad Stock Exchange
Two new plants to aid topline growth: Nutraplus
Kopran jumps 15% on shares allotment to promoter group co
Ranbaxy plunges 20% on USFDA ban on Toansa API plant

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Active Pharmaceutical Ingredients

Rakesh Jhunjhunwala-backed Concord Biotech files draft papers to float IPO

Local manufacturing of 35 APIs started after PLI scheme: Mansukh Mandaviya

USFDA pulls up Aurobindo Pharma for manufacturing lapses at API plant

PE major CVC Capital Partners in talks to pick up minority stake in Shilpa Medicare’s API business

API imports stood at Rs 28,529 crore, exports at Rs 32,856 crore in FY21: Mansukh Mandaviya

Indian pharma firms go local seeking to end reliance on China

Need to boost local API production for India to become self-reliant in coming years: Unichem Laboratories

Budget 2017: Weighted deductions for incurring pharma R&D should continue

Hikal's Bengaluru unit undergoes 'successful' USFDA inspection

Continue to be positive on housing finance companies: SP Tulsian

Laurus Labs IPO opens: Analysts bullish but say valuations high

API imports from China move up to 65% in 2015-16

Sharon Bio up 20% on USFDA approval for API plant in Maharashtra

Expect growth to continue going forward: Lincoln Pharma

Cipla in pact with Russian firm for HIV, Hepatitis C drugs

USFDA observations on 2 units not to impact products: Natco

Alkem's Mandva plant gets establishment nod from USFDA

US API import ban applies only to one drug: Biocon CMD

Mankind Pharma to invest Rs 200 cr by mid-2016

Strides Shasun suspends production at Cuddalore unit block

Granules India gets USFDA nod for generic Ibuprofen tablets

Cadila to delist from Ahmedabad Stock Exchange

Two new plants to aid topline growth: Nutraplus

Kopran jumps 15% on shares allotment to promoter group co

Ranbaxy plunges 20% on USFDA ban on Toansa API plant